Progressive Care Inc.
Subsidiary PharmCo, LLC Earns
Top Performance
Scores From
Humana Inc.
Miami, FL -- August 22, 2018 --
InvestorsHub NewsWire
-- Progressive
Care Inc. (OTCQB:
RXMD), a
personalized healthcare services and technology
company,
today announced that its wholly
owned
subsidiary PharmCo, LLC has met all three
of the
performance
measures evaluated by Humana
Inc., a
leading health and well-being company,
as part of its Rx Quality Network
program.
As a result
of PharmCo's performance
scores in the first measurement
period, the company will receive the maximum
payout offered by Humana as part of
the program's rewards.
Provided
by Humana Pharmacy Solutions, a division of Humana Inc.,
the Rx
Quality Network focuses on the health outcomes of patient care
related to medication adherence, in addition to rewarding
pharmacies for adherence performance. The program aims to partner
with participating pharmacies to improve member adherence in
targeted drug classes, which may result in
higher-quality care. The quality-based network
rewards pharmacies on performance and establishes their pharmacy
in-network/preferred for PDP/MAPD
plans.
"We are very
proud of the
performance scores PharmCo Pharmacy received as part of Humana's Rx
Quality Network program. These scores are a testament to the quality of
care we offer patients," said S. Parikh Mars, Chief
Executive Officer of Progressive Care Inc. "It is our hope that,
as a result
of consistently strong adherence
results, physicians contracted with Humana will continue to lean on
PharmCo as a trusted, high-quality provider. We believe that our success
with initiatives
like this one will lead to more opportunities for growth
and
allow us
to
provide even more
patients with Progressive Care's
adherence
packaging, proactive engagement model and pharmacological
expertise."
PharmCo Pharmacy
received the following performance scores for the months of January
2018 June 2018:
The first
measurement period is January through June of each calendar year
and the second period is January through December of each calendar
year. Performance used for these measurement periods will be
displayed in EQuIPP in August and February,
respectively, due
to the data refresh cycles. Humana will pay each participating
pharmacy 50 percent of the performance payment calculated with
respect to the January through June measurement period after the
calculation for that measurement period. This payment amount will
be deducted from the performance payment calculated for the second
measurement period of January through December (full year
calculation), which will be paid after the calculation for that
measurement period.
The
following targeted
drug classes are directly tied to the Centers for Medicare &
Medicaid Services Part D Stars adherence measures:
- Diabetes
Medications: Non-insulin diabetes medications (including
biguanides, sulfonylureas, DPP-IV inhibitors, TZDs, incretin
mimetics, meglitinides and SGLT2 inhibitors)
- Hypertension
Medications: Renin angiotensin system (RAS) antagonists (including
ACE inhibitors, ARBs and direct renin inhibitors)
- Cholesterol
Medications: Statins
Progressive
Care continues
to
make advances in becoming a leader in personalized healthcare and
tele-pharmacy services through
its many efforts to expand and educate its network.
Earlier
this month, Progressive Care earned its
LegitScript
certification verifying
PharmCo Pharmacy to be a safe and credible online health
resource. The
company also recently launched
DischargeRx, a
new program designed to improve engagement between hospitals and
patients, designed to help hospitals
like Westchester General provide
the best transitional care to its patients, while still preserving
hospital resources.
Go to
Humana.com/Pharmacy to learn more about
Humana
Pharmacy
Solutions and its Rx
Quality Network program.
For
more information about Progressive Care, please visit the
company's website.
Connect and stay
in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care
Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida
health services organization and provider of prescription
pharmaceuticals, compounded medications, provider of tele-pharmacy
services, the sale of anti-retroviral medications, medication
therapy management (MTM), the supply of prescription medications to
long term care facilities, and health practice risk
management.
About Humana Pharmacy Solutions
Humana Pharmacy
Solutions, a division of Humana Inc., manages traditional pharmacy
benefits with member-focused strategies to yield savings in
pharmacy and total health expense. Providing prescription coverage
for both individuals and employer groups, Humana Pharmacy Solutions
strives to give members access to the medicine they need while
offering guidance on clinically proven, therapeutically equivalent
drugs that bring better value to the member and the customer. For
more information visit www.Humana.com/Pharmacy.
Cautionary Statement Regarding Forward Looking
Statements
Statements contained herein that are not based upon current
or historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company's
expectations about its future operating results, performance and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words "anticipate," "believe," "estimate," "upcoming,"
"plan," "target," "intend" and "expect" and similar expressions, as
they relate to Progressive Care Inc., its subsidiaries, or its
management, are intended to identify such forward-looking
statements. These forward-looking statements are based on
information currently available to the Company and are subject
to a number of risks, uncertainties, and other
factors that could cause the Company's actual results, performance,
prospects, and opportunities to differ materially from those
expressed in, or implied by, these forward-looking
statements.
Public Relations Contact:
Tory Patterson,
CMW Media
Tory@cmwmedia.com
www.cmwmedia.com
Investor Relations Contact:
Armen
Karapetyan, Progressive Care
Senior Advisor
Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com